课题基金 / 基金详情

APPROARCH AT MOLECULAR LEVEL FOR MECHANISMS OF MULTIDRUG-RESISTANCE AND ENHANCEMENT OF ANTICANCER DRUGS WITH HYPERTHERMIA

APPROARCH AT MOLECULAR LEVEL FOR MECHANISMS OF MULTIDRUG-RESISTANCE AND ENHANCEMENT OF ANTICANCER DRUGS WITH HYPERTHERMIA
分子水平的多药耐药机制和热疗增强抗癌药物的研究
批准号:
11670890
负责人:
KAWASAKI Shoji
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

KAWASAKI Shoji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is an important problem that tumor cells treated with anticancer drugs expressed multidrug resistance. Therfore, resistant mechanisms of varius mammalian cells were studied, MDR1 gene concerning resistance to adriamycin were appeared in our established cells of Ehrlich ascites tumor. Its resistance related to eflux pump of p-gp which is in cellular membrane, and the penetration of adriamycin into cells was affected by both of ion channels of Na^+/H^+ and Cl^-/HCO_3. Heating showed marked enhancement of cell killing effects of adriamycin. Abtitumor effects of adriamycin were tested on in vivo with or without treatment of mild hyperthermia. However, antitumor effects were shown not so much. On the other hand, efflux of adriamycin was inhibited with cepharanthine, that is, cepharanthine enhanced a killing effect of adriamycin. Antitumor effects of adriamycin were affected with intraa- and extracellure pH. Intracellular accumulation of adriamycin was small amount at acidic condition. It was depended to slow infflux of adriamycin. It is concluded that antitumor effects of adriamycin were not so large enhancement with hyperthermia as it is low pH condition in tumor and hyperthermia induced low pH more than without treatment. On the othe hand, those cells showed the other unknown resistant mechanisims to adriamycin. It is indicated that adriamysin-resistant cells of Ehrlich ascites tumor have at least two expression processes of resistance to adriamycin. There are many mechanisms on resistant to anticancer drugs. Hyperthermia enhanced markedly killing effects of alkylating agents in vitro and in vivo. The sensitivity to alkylating agents related to 06-methylguanine-DNA methyltransferase(MGMT). As MGMT expression was depressed by methylation, it is investigated that relationship between level of methylation and killing effect of alkylating agent in several human squarmous carcinoma cells. Methylation of MGMT is closely related to the sennsitivity for alkylating agents.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Asaumi J, Matsuzaki H, Kawasaki S, Kuroda M, Takeda Y, Kishi K, and Hiraki Y: "Influence of bovine calf serum on the intracellular accumulation and retention of adriamycin"Anticancer Research. 20 (2A). 769-772 (2000)
Asaumi J、Matsuzaki H、Kawasaki S、Kuroda M、Takeda Y、Kishi K 和 Hiraki Y:“小牛血清对阿霉素细胞内积累和保留的影响”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Asaumi J, Higuchi Y, Matsuzaki H, Murakami J, Kawasaki S, Kuroda M, Shibuya K, Konouchi H, Hisatomi M, Wakasa T, Kishi K, and Hiraki Y: "Thermochemotherapy of a human sailvary adenocarcmoma cell line."Oncol Rep.. 9 (2). 365-369 (2002)
Asaumi J、Higuchi Y、Matsuzaki H、Murakami J、Kawasaki S、Kuroda M、Shibuya K、Konouchi H、Hisatomi M、Wakasa T、Kishi K 和 Hiraki Y:“人帆腺癌细胞系的热化疗。”Oncol Rep
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Power Quality Improvement of Distribution Network by Utilizing PowerConditioner Systems of Distributed Generator
  • 批准号:
    22560268
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2010
  • 负责人:
    KAWASAKI Shoji
  • 依托单位:
Study on Harmonic Analysis of Distribution Network Connected Distributed Generators
  • 批准号:
    19560285
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2007
  • 负责人:
    KAWASAKI Shoji
  • 依托单位:
Research at molecular and gene level on enhancement mechanisms combined with irradiation and hyperthermia in culture cell lines
  • 批准号:
    15591277
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2003
  • 负责人:
    KAWASAKI Shoji
  • 依托单位:
海外基金